← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. ENOV
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

ENOV logoEnovis Corporation (ENOV) P/E Ratio History

Historical price-to-earnings valuation from 2009 to 2022

Current P/E
-1.3
Undervalued
5Y Avg P/E
40.0
-103% vs avg
PE Percentile
0%
Low
PEG Ratio
N/A
N/A
TTM EPSN/A
Price$27.27
5Y PE Range10.3 - 214.1
Earnings YieldN/A

Loading P/E history...

ENOV Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
-1.3vs40.0
-103%
Cheap vs History
vs. Industrials
-1.3vs25.5
-105%
Below Sector
vs. S&P 500
-1.3vs25.1
-105%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -40% EPS growth (1Y)
Export Data

P/E Ratio Analysis

The current P/E is 103% below its 5-year average of 40.0x. Over the past five years, ENOV's P/E has ranged from a low of 10.3x to a high of 214.1x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Industrials sector median P/E of 25.5x, ENOV trades at a 105% discount to its sector peers. The sector includes 413 companies with P/E ratios ranging from 0.0x to 185.3x.

Relative to the broader market, ENOV trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ENOV DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ENOV P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
INVA logoINVAInnoviva, Inc.
$2B6.9Lowest0.67Best+817%Best
LMAT logoLMATLeMaitre Vascular, Inc.
$2B42.82.21+31%
ZBH logoZBHZimmer Biomet Holdings, Inc.
$16B23.5--20%
SNN logoSNNSmith & Nephew plc
$13B20.92.92+53%
GMED logoGMEDGlobus Medical, Inc.
$12B21.70.70+423%
AORT logoAORTArtivion, Inc.
$2B168.5-+166%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

ENOV Historical P/E Data (2009–2022)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2022 Q4Sat Dec 31 2022 00:00:00 GM$53.52$0.25214.1x+571%
FY2022 Q3Fri Sep 30 2022 00:00:00 GM$46.07$1.2337.5x+17%
FY2022 Q2Fri Jul 01 2022 00:00:00 GM$56.00$2.9519.0x-41%
FY2022 Q1Fri Apr 01 2022 00:00:00 GM$69.86$1.3053.7x+68%
FY2021 Q4Fri Dec 31 2021 00:00:00 GM$79.12$1.4255.7x+75%
FY2021 Q3Fri Oct 01 2021 00:00:00 GM$81.05$2.1737.4x+17%
FY2021 Q2Fri Jul 02 2021 00:00:00 GM$80.86$1.9840.8x+28%
FY2021 Q1Fri Apr 02 2021 00:00:00 GM$76.35$1.2362.1x+94%
FY2020 Q4$65.82$0.9271.5x+124%
FY2019 Q1Fri Mar 29 2019 00:00:00 GM$51.08$1.7129.9x-6%
FY2018 Q4Mon Dec 31 2018 00:00:00 GM$35.97$3.4810.3x-68%
FY2018 Q3Fri Sep 28 2018 00:00:00 GM$62.07$2.6123.8x-25%

Average P/E for displayed period: 31.9x

See ENOV's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ENOV Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ENOV vs SPIR

Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..

Start Comparison

ENOV — Frequently Asked Questions

Quick answers to the most common questions about buying ENOV stock.

Is ENOV stock overvalued or undervalued?

ENOV trades at -1.3x P/E, below its 5-year average of 40.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does ENOV's valuation compare to peers?

Enovis Corporation P/E of -1.3x compares to sector median of 25.5x. The discount suggests lower growth expectations or higher risk.

What is ENOV's PEG ratio?

ENOV PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2009-2022.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ENOV P/E Ratio History (2009–2022)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.